THE DEAL, AT A GLANCE
From the announcementFlare Therapeutics
01What it doesADVERTISEMENT "This is an exciting time for Flare Therapeutics and for patients with prostate cancer who desperately need new options.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Pfizer Ventures, Boxer Capital, GordonMD Global Investments® LP, InvusFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedFlare Therapeutics raised $85M Series C, announced 2026-06-30From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersFlare Therapeutics is using an $85M insider-led Series C to advance its ARON RIPTAC program through preclinical development and support a CEO transition under Anna…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Flare Therapeutics · Financing Record
Explore source-linked visual explanations for Flare Therapeutics. Unsupported claims are withheld while source review continues.
Record 7000 · Recorded date: 2026-06-30
Explore company records →